$UGP Cashflow Statement | Understand Stock

$UGP

$6.12 -$0.28 (4.38%) Close

$UGP Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows - indirect method

In millions of BRL, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
CASH FLOWS FROM CONTINUING OPERATING ACTIVITIES
Net income from continuing operations
Adjustments to reconcile net income to cash provided (consumed) by operating activities
Share of profit (loss) of subsidiaries, joint ventures and associates and amortization of fair value adjustments on associates acquisition
Amortization of contractual assets with customers - exclusivity rights
Amortization of right-of-use assets
Depreciation and amortization
PIS and COFINS credits on depreciation
Interest, monetary variations and foreign exchange variations
Deferred income and social contribution taxes
Current income and social contribution taxes
Current and deferred income and social contribution taxes
Gain (loss) on disposal or write-off of assets
Reversal (loss) allowance for expected credit losses
Provision (reversal) for losses with inventories
Provision for post-employment benefits
Equity instrument granted
Gain (loss) on the fair value of energy contracts
Provision for decarbonization - CBIO
Revaluation of investment in associates
Provisions for tax, civil and labor risks
Other provisions and adjustments

Cash flows from operations before changes in working capital
(Increase) decrease in assets
Trade receivables and reseller financing
Inventories
Recoverable taxes
Dividends received from subsidiaries, associates and joint ventures
Other receivables
Prepaid expenses
Other assets

Increase (decrease) in liabilities
Trade payables and trade payables - reverse factoring
Salaries and related charges
Post-employment benefits
Other payables
Deferred revenue
Trade receivables and reseller financing
Recoverable taxes
Escrow deposits
Other receivables
Prepaid expenses
Provision for tax, civil, and labor risks
Taxes payable
Income and social contribution taxes payable
Other liabilities

Acquisition of CBIO and carbon credits
Payments of contractual assets with customers - exclusivity rights
Payment of contingencies
Income and social contribution taxes paid
Net cash provided by continuing operating activities
Net cash provided by discontinued operating activities
Net cash provided by operating activities
CASH FLOWS FROM INVESTING ACTIVITIES
Financial investments, net of redemptions
Acquisition of property, plant and equipment
Acquisition of intangible assets
Revenue on disposal of investments
Acquisition of property, plant and equipment and intangible assets
Receipt of intercompany loan owed by Oxiteno S.A. to Ultrapar International
Capital increase in joint ventures
Capital decrease in associates
Capital decrease in joint ventures
Sale of investments and other assets
Acquisition of investments and other assets
Cash acquired in business combination
Transactions with discontinued operations
Investment purchase and sale transactions and other assets
Initial direct costs of right-of-use assets
Receipt from related parties
Proceeds from disposal of property, plant, and equipment and intangibles
Net cash consumed by continuing investing activities
Net cash consumed by discontinued investing activities
Net cash consumed by investing activities

CASH FLOWS FROM FINANCING ACTIVITIES
Loans, financing and debentures
Proceeds
Repayments
Interest and derivatives (paid) or received
Payments of lease
Principal and interest paid
Interest paid
Dividends paid
Proceeds from financial liabilities of customers
Payments of financial liabilities of customers
Capital increase made by non-controlling shareholders and redemption of shares
Repurchase of treasury shares
Related parties
Net cash consumed by continuing financing activities
Net cash consumed by discontinued financing activities
Net cash consumed by financing activities
Effect of exchange rate changes on cash and cash equivalents in foreign currency - continuing operations
Effect of exchange rate changes on cash and cash equivalents in foreign currency - discontinued operations
Increase (decrease) in cash and cash equivalents
Increase (decrease) in cash and cash equivalents - continuing operations
Increase (decrease) in cash and cash equivalents - discontinued operations
Cash and cash equivalents at the beginning of the year
Cash and cash equivalents at the end of the year
Cash and cash equivalents at the beginning of the year - continuing operations
Cash and cash equivalents at the beginning of the year - discontinued operations
Cash and cash equivalents at the end of the year - continuing operations
Non-cash transactions:
Addition and remeasurement on right-of-use assets and leases payable
Addition on contractual assets with customers - exclusivity rights
Reclassification between financial assets and investment in associates
Transfer between trade receivables and other assets accounts
Issuance of shares related to the subscription warrants - indemnification - Extrafarma acquisition
Acquisition of property, plant and equipment and intangible assets without cash effect
Withdrawal of escrow deposits with tax contingencies
Contingent consideration – acquisition of subsidiaries
Capital increase performed by non-controlling interests
Reversal fund - private pension

Comments